Search Results - "Marosi, C."

Consequence of the magnocellular dysfunction on processing facial affect recognition in Schizophrenia by Marosi, C., Fodor, Z., Csukly, G.

“…Introduction Magnocellular deficit in visual perception and impaired emotion recognition are core features of schizophrenia, however their relationship and the…”
Get full text

Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients by THALER, J., AY, C., MACKMAN, N., BERTINA, R. M., KAIDER, A., MAROSI, C., KEY, N. S., BARCEL, D. A., SCHEITHAUER, W., KORNEK, G., ZIELINSKI, C., PABINGER, I.

“…Background:  Tissue factor (TF) expression by tumors contributes to tumor growth. Release of TF‐positive microparticles (MPs) may contribute to venous…”
Get full text

Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism by Mir Seyed Nazari, P., Riedl, J., Preusser, M., Posch, F., Thaler, J., Marosi, C., Birner, P., Ricken, G., Hainfellner, J. A., Pabinger, I., Ay, C.

“…Essentials Risk stratification for venous thromboembolism (VTE) in patients with brain tumors is challenging. Patients with IDH1 wildtype and high podoplanin…”
Get full text

Working Memory Deficit and Attentional Distractibility in Schizophrenia by Becske, M., Marosi, C., Molnár, H., Fodor, Z., Tombor, L., Csukly, G.

“…Introduction Meta-analyses suggest that patients with schizophrenia show deficit in working memory – both verbal and visual – and are more distractible…”
Get full text

Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment by Reitter, E.‐M., Kaider, A., Ay, C., Quehenberger, P., Marosi, C., Zielinski, C., Pabinger, I.

“…Essentials Hemostasis biomarkers impact thrombosis occurrence and survival in cancer patients. We performed a longitudinal analysis of hemostatic parameters in…”
Get full text

Light at the end of the tunnel: towards an effective drug therapy for surgery- and radiation-refractory meningioma by Marosi, Christine

Get full text

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients – results from the Vienna Cancer And Thrombosis Study (CATS) by Pabinger, I., Ay, C., Dunkler, D., Thaler, J., Reitter, E.‐M., Marosi, C., Zielinski, C., Mannhalter, C.

“…Summary Background Patients with cancer are at an increased risk for venous thromboembolism (VTE). The risk varies markedly in different patient populations…”
Get full text

Timely integration of palliative care. the reality check. a retrospective analysis by Adamidis, F., Baumgartner, N. S., Kitta, A., Kum, L., Ecker, F, Bär, J, Marosi, C., Kreye, G., Fischer, C., Zeilinger, E. L., Paschen, C., Wenzel, C., Masel, E. K.

“…Purpose A large volume of literature suggests that timely integration of palliative care (PC) enhances the well-being, quality of life and satisfaction of…”
Get full text

High Factor VIII Levels Independently Predict Venous Thromboembolism in Cancer Patients: The Cancer and Thrombosis Study by Vormittag, R, Simanek, R, Ay, C, Dunkler, D, Quehenberger, P, Marosi, C, Zielinski, C, Pabinger, I

“…OBJECTIVE—Patients with cancer are at an increased risk for venous thromboembolism (VTE). Clotting factor VIII activity (FVIII) has been established as risk…”
Get full text

Applied Precision Cancer Medicine in Neuro-Oncology by Taghizadeh, H., Müllauer, L., Furtner, J., Hainfellner, J. A., Marosi, C., Preusser, M., Prager, G. W.

“…Brain tumours that are refractory to treatment have a poor prognosis and constitute a major challenge in offering effective treatment strategies. By targeting…”
Get full text

The course of quality of life and neurocognition in newly diagnosed patients with glioblastoma by Flechl, B., Sax, C., Ackerl, M., Crevenna, R., Woehrer, A., Hainfellner, J., Preusser, M., Widhalm, G., Kiesel, B., Lütgendorf-Caucig, C., Dieckmann, K., Steffal, C., Marosi, C., Hassler, M.R.

“…The importance of QoL and neurocognitive functions in patients with glioblastoma (GB) is above controversy by now. We followed newly diagnosed GB patients…”
Get full text

Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma? by Schoenegger, K., Oberndorfer, S., Wuschitz, B., Struhal, W., Hainfellner, J., Prayer, D., Heinzl, H., Lahrmann, H., Marosi, C., Grisold, W.

“…Background:  Peritumoral brain edema in glioblastoma patients is a frequently encountered phenomenon that strongly contributes to neurological signs and…”
Get full text

EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force by Soffietti, R., Cornu, P., Delattre, J. Y., Grant, R., Graus, F., Grisold, W., Heimans, J., Hildebrand, J., Hoskin, P., Kalljo, M., Krauseneck, P., Marosi, C., Siegal, T., Vecht, C.

“…The objectives have been to establish evidence‐based guidelines and identify controversies regarding the management of patients with brain metastases. The…”
Get full text

End of life care in high-grade glioma patients in three European countries: a comparative study by Koekkoek, J. A. F., Dirven, L., Reijneveld, J. C., Sizoo, E. M., Pasman, H. R. W., Postma, T. J., Deliens, L., Grant, R., McNamara, S., Grisold, W., Medicus, E., Stockhammer, G., Oberndorfer, S., Flechl, B., Marosi, C., Taphoorn, M. J. B., Heimans, J. J.

“…Exploring cross-national differences is useful to evaluate whether different patterns of end of life (EOL) care meet patient’s specific needs. This study aimed…”
Get full text

Arterial spin-labeling assessment of normalized vascular intratumoral signal intensity as a predictor of histologic grade of astrocytic neoplasms by Furtner, J, Schöpf, V, Schewzow, K, Kasprian, G, Weber, M, Woitek, R, Asenbaum, U, Preusser, M, Marosi, C, Hainfellner, J A, Widhalm, G, Wolfsberger, S, Prayer, D

“…Pulsed arterial spin-labeling is a noninvasive MR imaging perfusion method performed with the use of water in the arterial blood as an endogenous contrast…”
Get full text

FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities by Allerstorfer, S, Sonvilla, G, Fischer, H, Spiegl-Kreinecker, S, Gauglhofer, C, Setinek, U, Czech, T, Marosi, C, Buchroithner, J, Pichler, J, Silye, R, Mohr, T, Holzmann, K, Grasl-Kraupp, B, Marian, B, Grusch, M, Fischer, J, Micksche, M, Berger, W

“…Fibroblast growth factor 5 (FGF5) is widely expressed in embryonic but scarcely in adult tissues. Here we report simultaneous overexpression of FGF5 and its…”
Get full text

Mutational and inflammatory microenvironment characteristics in primary and matched local recurrent non-small cell lung cancer brain metastases by Berghoff, A.S., Erguener, B., Schuster, M.R., Rajky, U., Ricken, G., Frischer, J.M., Gatterbauer, B., Marosi, C., Dieckmann, K., Widhalm, G., Bock, C., Preusser, M.

Get full text

Hypothyroidism is associated with improved survival prognosis in patients with newly diagnosed brain metastases by Wippel, C., Starzer, A.M., Berghoff, A.S.S., Bergen, E., Wolf, P., Widhalm, G., Frischer, J.M., Gatterbauer, B., Marosi, C., Dieckmann, K., Bartsch, R., Preusser, M.

Get full text

PL3.2 Trabectedin for recurrent WHO grade II or III meningioma: a randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG) by Preusser, M, Silvani, A, Le Rhun, E, Soffietti, R, Lombardi, G, Sepulveda, J, Brandal, P, Beaney, R, Bonneville-Levard, A, Lorgis, V, Bromberg, J, Erridge, S, Cameron, A, Marosi, C, Golfinopoulos, V, Gorlia, T, Weller, M, Wick, W

“…Abstract BACKGROUND EORTC-1320-BTG investigated the activity, safety and quality of life of therapy with the tetrahydroisoquinoline alkaloid trabectedin…”
Get full text

Glioblastoma treatment using perphenazine to block the subventricular zone’s tumor trophic functions by Kast, R. E., Ellingson, B. M., Marosi, C., Halatsch, M.-E.

“…We present here a potential new treatment adjunct for glioblastoma. Building on murine studies, a series of papers appeared recently showing that therapeutic…”
Get full text